Promises and Perils of Emerging Technologies for Human Condition: Voices from Four Postcommunist Central and East European Countries

ISBN-13: 9783631775127 / Angielski / Twarda / 2019 / 208 str.

Peter Sýkora

Opis

Emerging technologies are defined as fast-growing radically novel technologies with an estimated prominent impact on human society in the future. The ambiguity and uncertainty of emerging technologies at the same time raise techno-optimistic expectations, as well as serious worries about possible unwanted and unpredicted negative consequences following their introduction into wider practice. And because of their radical novelty, emerging technologies also challenge various traditional philosophical and ethical concepts, established risk assessment methods, science and technology governance and policies, science to public communication and practices within and outside the medical domain. The aim of this volume is to present the view of ten authors from four postcommunist Central and East European countries (Czech Republic, Slovakia, Poland and Latvia) on emerging technologies and human enhancement. They analyse the topic from various perspectives: anthropological, ethical, philosophical, ontological, empirical, and legal. A variety of views will contribute to a development of the discourse on technology assessment in their countries, help to make the process of national policy and law formation more active and less "mimetic", and open the national discourses to international discussion and critical analysis.

Spis treści

Emerging technologies - Multidisciplinary approach - Transhumanism - Posthumanism - Liminality - Immortality - Capability approach - Pragmatist view on transhumanism - Synthetic biology - Germline genome editing - Focus group study on emerging technologies - Cognitive enhancement and Polish civil liability

O autorze

Peter Sýkora is Professor of Philosophy and Director of the Centre for Bioethics, University of Ss. Cyril and Methodius in Trnava, Slovak Republic. His recent publication is on Germline Gene Therapy in the Era of Precise Genome Editing.